Oscar Health Inc. (OSCR) Tops Q2 EPS by 73c ; Offers Guidance

Oscar Health Inc. (NYSE: OSCR) reported Q2 EPS of $1.10, $0.73 better than the analyst estimate of $0.37. Revenue for the quarter came in at $4.88 billion versus the consensus estimate of $4.73 billion.

GUIDANCE:

Oscar Health Inc. sees FY2026 revenue of $18.7-19 billion, versus the consensus of $18.57 billion.

For earnings history and earnings-related data on Oscar Health Inc. (OSCR) click here.

You May Also Be Interested In

• GameStop CEO Cohen buys 1.15M shares
• Innovent Biologics Inc. (1801:HK) (IVBXF) PT Raised to HK$128 at Bernstein SocGen Group
• Catalyst Metals Ltd (CYL:AU) PT Lowered to AUD9.25 at UBS